

Nodal Burden and Oncologic Outcomes in Patients WithResidual Isolated Tumor Cells After NeoadjuvantChemotherapy (ypN0i1): The OPBC-05/ICARO Study
https://15d4b329-4562-4630-88f6-09f3fae0e94a.usrfiles.com/ugd/6365b0_8b8e745539014dffb0838d2e277b6c8a.pdf


Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer.
Atilla Soran, MD, MPH, FNCBC , Ozgur Aytac, MD, FEBS and Serdar Ozbas, MD, FEBS


18F-FDG PET/CT in Early Stage Breast Cancer Comes with Financial Burden
Atilla Soran, MD, MPH, FACS, Mehmet Ali Nazlı, MD, Osman Toktas, MD, and Serdar Ozbas, MD, FEBS